Record drug approvals and progress in addressing opioid misuse and stemming the spread of infectious diseases are among the many advances in 2017 reported by federal health and science agencies.
In a year-end article, the National Institutes of Health (NIH) shared developments on two Ebola vaccines and a bionic pancreas that could simplify how type 1 diabetics manage their illness. In its Public Health Grand Rounds Year in Review, the Centers for Disease Control and Prevention (CDC) highlighted approaches to addressing the unique challenges of opioid use disorder in women and also featured methods for overcoming barriers to medication adherence for chronic diseases.
National Science Foundation (NSF) researchers discovered Alzheimer’s-related proteins in a sample of aged chimpanzee brains, a finding that could improve our understanding of the brain and Alzheimer’s disease. Tools developed by the Agency for Healthcare Research and Quality (AHRQ) helped reduce infections and medical errors in hospitals, and the Food and Drug Administration (FDA) approved 46 novel drug applications, more than double approvals in 2016.
For more on each agency’s 2017 accomplishments, click here.